The No Surprises Act, signed by President Trump in 2020, protects consumers from surprise medical bills and established a payment negotiation process between medical providers and health plans. It was found that only 1 in 8 out-of-network billing disputes went to the federal dispute resolution (IDR) process. The government proposed changes to increase early communication and efficiency in IDR.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
